Indian ministers and officials were following Prime Minister Narendra Modi lead by opting for a "homegrown" COVID-19 vaccine approved without late-stage efficacy data, instead of AstraZeneca.
India's health, foreign and law ministers, and state governors, all flocked to Twitter to express support for the much-criticised Bharat Biotech's COVAXIN vaccine, after it was administered to Modi on Monday.
"Made-in-India vaccines are 100 per cent safe," Health Minister Harsh Vardhan said after being inoculated with COVAXIN.
Many state officials and doctors have refused to take COVAXIN before its effectiveness could be proved.
Bharat Biotech says it has completed the late-stage trial and results will be out this month.
The company said the endorsement by Modi and other ministers would set an example for other Indians and reduce "vaccine hesitancy".
It is seeking to sell COVAXIN to countries including Brazil and the Philippines.
COVAXIN and the AstraZeneca vaccines were approved by India's regulator in January. The government has distributed to states a total of 50 million doses of the vaccines but only 12 per cent of the 12 million people immunised so far have taken COVAXIN, according to government data.
Ukraine issued air raid alerts for Kyiv and the country's eastern half as blasts shook the city of Mykolaiv early on Monday, authorities said, hours after the one-day Easter ceasefire declared by Russian President Vladimir Putin came to an end.
US Vice President JD Vance began a four-day visit to India on Monday and will hold talks with Prime Minister Narendra Modi, as New Delhi rushes to avoid steep US tariffs with an early trade deal and boost ties with the Trump administration.
The Israeli military on Sunday said a review into last month's killing of emergency responders in Gaza found there had been "several professional failures" and that a commander would be dismissed over the incident.
US President Donald Trump is threatening to cut another $1 billion in funding for Harvard University, this time targeting health research, the Wall Street Journal reported on Sunday, as the administration's row with elite schools escalated.